Williams Nigel M, Green Elaine K, Macgregor Stuart, Dwyer Sarah, Norton Nadine, Williams Hywel, Raybould Rachel, Grozeva Detelina, Hamshere Marian, Zammit Stanley, Jones Lisa, Cardno Alastair, Kirov George, Jones Ian, O'Donovan Michael C, Owen Michael J, Craddock Nick
Department of Psychological Medicine and Biostatistics and Bioinformatics Unit, Wales School of Medicine, Cardiff University.
Arch Gen Psychiatry. 2006 Apr;63(4):366-73. doi: 10.1001/archpsyc.63.4.366.
Variation at the DAOA/G30 locus has been described to be associated with both schizophrenia and bipolar disorder, but there is little consistency between studies of the tested polymorphisms or variants showing association.
To obtain a stringent replication of association in large samples of both disorders using consistent clinical and laboratory methods, and to test the hypothesis that association at DAOA/G30 identifies an underlying domain of psychopathological abnormalities that cuts across traditional diagnostic categories.
A systematic study of polymorphisms at DAOA/G30 using genetic case-control association analysis.
Subjects were unrelated and ascertained from general psychiatric inpatient and outpatient services.
White persons from the United Kingdom meeting criteria for DSM-IV schizophrenia (n = 709) or bipolar I disorder (n = 706) and 1416 ethnically matched controls.
Nine polymorphisms that tag common genetic variations at DAOA/G30 were genotyped in all of the individuals, and comparisons were made between affected and unaffected individuals.
We identified significant association (P = .01-.047) between 3 single-nucleotide polymorphisms and bipolar disorder but failed to find association with schizophrenia. Analyses across the traditional diagnostic categories revealed significant evidence (P = .002-.02) for association with 4 single-nucleotide polymorphisms in the subset of cases (n = 818) in which episodes of major mood disorder had occurred (gene-wide P = .009). We found a similar pattern of association in bipolar cases and in schizophrenia cases in which individuals had experienced major mood disorder. In contrast, we found no evidence for association in the subset of cases (n = 1153) in which psychotic features occurred (all P>.08).
Despite being originally described as a schizophrenia susceptibility locus, our data suggest that variation at the DAOA/G30 locus does not primarily increase susceptibility for prototypical schizophrenia or psychosis. Instead, our results imply that variation at the DAOA/G30 locus influences susceptibility to episodes of mood disorder across the traditional bipolar and schizophrenia categories.
已有研究表明,DAOA/G30基因座的变异与精神分裂症和双相情感障碍均有关联,但在所检测的显示关联的多态性或变体的研究之间,一致性较差。
采用一致的临床和实验室方法,在这两种疾病的大样本中严格重复关联研究,并检验DAOA/G30基因座的关联识别出跨越传统诊断类别的精神病理异常潜在领域这一假设。
采用遗传病例对照关联分析,对DAOA/G30基因座的多态性进行系统研究。
受试者为非亲属关系,来自普通精神科住院和门诊服务机构。
符合《精神疾病诊断与统计手册》第四版(DSM-IV)精神分裂症标准的英国白人(n = 709)或双相I型障碍患者(n = 706),以及1416名种族匹配的对照者。
对所有个体进行基因分型,检测9个标记DAOA/G30常见基因变异的多态性,并对患病个体和未患病个体进行比较。
我们发现3个单核苷酸多态性与双相情感障碍之间存在显著关联(P = 0.01 - 0.047),但未发现与精神分裂症有关联。对传统诊断类别进行分析发现,在出现过重度心境障碍发作的病例子集(n = 818)中(全基因P = 0.009),有显著证据(P = 0.002 - 0.02)表明4个单核苷酸多态性存在关联。在双相情感障碍病例以及经历过重度心境障碍发作的精神分裂症病例中,我们发现了类似的关联模式。相比之下,在出现精神病性症状的病例子集(n = 1153)中,我们未发现关联证据(所有P > 0.08)。
尽管DAOA/G30基因座最初被描述为精神分裂症易感基因座,但我们的数据表明,该基因座的变异并非主要增加典型精神分裂症或精神病的易感性。相反,我们的结果表明,DAOA/G30基因座的变异影响了跨越传统双相情感障碍和精神分裂症类别的心境障碍发作的易感性。